Search

Your search keyword '"Gauthier BR"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Gauthier BR" Remove constraint Author: "Gauthier BR" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
57 results on '"Gauthier BR"'

Search Results

1. Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging

2. Human Omental Mesothelial Cells Impart an Immunomodulatory Landscape Impeding B- and T-Cell Activation

Catalog

Books, media, physical & digital resources

3. Diallel panel reveals a significant impact of low-frequency genetic variants on gene expression variation in yeast

4. Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy

5. Non-additive genetic components contribute significantly to population-wide gene expression variation

6. Metasurface orbital angular momentum holography

7. The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity

8. Nuclear envelope integrity in health and disease: Consequences on genome instability and inflammation

9. Harnessing the endogenous plasticity of pancreatic islets: A feasible regenerative medicine therapy for diabetes?

10. The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease

11. Thyroid hormones in diabetes, cancer, and aging

12. Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy

13. LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus

14. PAX4 Defines an Expandable β-Cell Subpopulation in the Adult Pancreatic Islet

15. Enhancing human islet xenotransplant survival and function in diabetic immunocompetent mice through LRH-1/NR5A2 pharmacological activation.

16. Hydroxycitrate delays early mortality in mice and promotes muscle regeneration while inducing a rich hepatic energetic status.

17. The PTGS2/COX2-PGE 2 signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus.

18. Enzyme-Responsive Zr-Based Metal-Organic Frameworks for Controlled Drug Delivery: Taking Advantage of Clickable PEG-Phosphate Ligands.

19. Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging.

20. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses.

21. Roles of extracellular vesicles associated non-coding RNAs in Diabetes Mellitus.

22. NR5A2/LRH-1 regulates the PTGS2-PGE 2 -PTGER1 pathway contributing to pancreatic islet survival and function.

24. Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.

25. Physical Forces and Transient Nuclear Envelope Rupture during Metastasis: The Key for Success?

26. Nuclear Envelope Integrity in Health and Disease: Consequences on Genome Instability and Inflammation.

27. The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.

28. Harnessing the Endogenous Plasticity of Pancreatic Islets: A Feasible Regenerative Medicine Therapy for Diabetes?

29. Thyroid hormones in diabetes, cancer, and aging.

30. The T1D-associated lncRNA Lnc13 modulates human pancreatic β cell inflammation by allele-specific stabilization of STAT1 mRNA.

31. The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.

32. Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration.

33. Molecular Modelling of Islet β-Cell Adaptation to Inflammation in Pregnancy and Gestational Diabetes Mellitus.

34. Inadequate control of thyroid hormones sensitizes to hepatocarcinogenesis and unhealthy aging.

35. Pancreatic alpha-cell mass in the early-onset and advanced stage of a mouse model of experimental autoimmune diabetes.

37. Advances in Genetics of Regeneration in Metabesity.

38. Dissecting the Brain/Islet Axis in Metabesity.

39. Transient PAX8 Expression in Islets During Pregnancy Correlates With β-Cell Survival, Revealing a Novel Candidate Gene in Gestational Diabetes Mellitus.

40. Therapeutic potential of pancreatic PAX4-regulated pathways in treating diabetes mellitus.

41. Targeting LRH-1/NR5A2 to treat type 1 diabetes mellitus.

42. LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus.

43. GATA6 Controls Insulin Biosynthesis and Secretion in Adult β-Cells.

44. The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity.

46. Levothyroxine enhances glucose clearance and blunts the onset of experimental type 1 diabetes mellitus in mice.

47. The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice.

48. The Diabetes-Linked Transcription Factor PAX4: From Gene to Functional Consequences.

49. Targeting pancreatic expressed PAX genes for the treatment of diabetes mellitus and pancreatic neuroendocrine tumors.

50. Endoplasmic Reticulum Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDL.